Tuesday, January 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Harvard Medical School Closing Primate Research Center

by Global Biodefense Staff
April 25, 2013

Non-Human Primate (NHP) ResearchHarvard Medical School announced this week it will be drawing down operations of the New England Primate Research Center (NEPRC) rather than seek to renew a five-year federal grant to continue operations.

The school indicated its leadership had begun to work with the National Institutes of Health (NIH) on a transition plan to end work at the facility within 12 to 24 months.

The news came as somewhat of a surprise to the primate research community. School leaders acknowledged that the decision was extremely difficult in light of the groundbreaking research that has been conducted at the center over the past several decades.

The current challenges and uncertainties of the external funding environment for scientific research were cited as a major factor in the decision. As Harvard Medical School leadership evaluated the long-term need to use its resources in the most effective manner across all of its missions, they came to the conclusion that winding down the operations of the NEPRC was more beneficial to the School than investing further resources in maintaining and renewing the NEPRC grant.

Research accomplishments made possible by NEPRC research with nonhuman primates include:

  •  First unambiguous evidence that AIDS is caused by a virus.
  •  Discovery of simian immunodeficiency virus (SIV) and development of the first animal model of AIDS.
  •  Original demonstration that vaccine protection against AIDS is possible.
  •  Discovery of the oncogenic herpesvirus, Herpesvirus saimiri.
  •  First nonhuman primate models of colon cancer and inflammatory bowel disease.
  •  Evidence leading to the use of hydroxyurea to treat sickle cell anemia.
  •  Discovery of stunned myocardium and its role in myocardial ischemia.
  •  First animal model for progressive neurodegeneration in Parkinson’s disease.
  •  Development of improved brain imaging techniques for early diagnosis of Parkinson’s disease.
  •  Development of novel cellular and pharmacological strategies for treatment of Parkinson’s disease. 

“We are extremely proud of the contributions the NEPRC has made to improving human heath over the past nearly 50 years,” said Jeffrey S. Flier, Dean of the Faculty of Medicine of Harvard University. “We believe primate research is critical to the future of biomedical research and the effective development of lifesaving therapies. The Center’s research focus on HIV, infectious disease and vaccines will continue to be effectively pursued through scientific programs throughout HMS.”

Read at Harvard: HMS to Wind Down Operations at Primate Research Center
Read at Science Insider: Harvard Medical School to Shutter Primate Research

Tags: Animal Models

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC